CCLabs has a total of 20 patents globally, out of which 5 have been granted. Of these 20 patents, more than 84% patents are active. United States of America is where CCLabs has filed the maximum number of patents, followed by Europe (EPO) and South Korea. Parallelly, United States of America seems to be the main focused R&D centre and Australia is the origin country of CCLabs.
CCLabs founded in 2019 in Melbourne, Cortical Labs is a biotechnology company developing biological computer chips that combine living neural cells with programmable machine systems. Its hybrid-biological computing platform supports applications in robotics, precision medicine, and next-generation intelligent computing through self-learning and adaptive technologies.
Do read about some of the most popular patents of CCLabs which have been covered by us in this article and also you can find CCLabs patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over CCLabs patent portfolio.
How many patents does CCLabs have?
CCLabs has a total of 20 patents globally. These patents belong to 7 unique patent families. Out of 20 patents, 17 patents are active.
How Many Patents did CCLabs File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | CCLabs Applications Filed | CCLabs Patents Granted |
| 2026 | – | 1 |
| 2025 | 2 | 2 |
| 2024 | 3 | 1 |
| 2023 | 1 | 1 |
| 2022 | 10 | – |
| 2021 | 1 | – |
| 2020 | 2 | – |
| 2019 | 1 | – |
How many CCLabs patents are Alive/Dead?
Worldwide Patents
How Many Patents did CCLabs File in Different Countries?
Countries in which CCLabs Filed Patents
| Country | Patents |
| United States of America | 9 |
| Europe (EPO) | 3 |
| Korea (South) | 2 |
| Australia | 2 |
| Germany | 1 |
Where are Research Centres of CCLabs Patents Located?
What Technologies are covered by CCLabs Patents?
CCLabs has established a unique position in the field of biological computing, with a focus on combining living neural systems with computational technologies. Rather than relying on conventional hardware alone, the company is developing bioelectronic platforms designed to create adaptive and energy-efficient intelligence systems.
A key reflection of this innovation is CCLabs’ patent portfolio, which spans Biological Computing, Bioelectronic Systems, In-Vitro Neural Platforms, and Neural Analysis Platforms. The company is also advancing technologies in Neural Data Processing and Cell Culture Automation, supporting the development and management of neuron-based computing environments. In addition, its innovations in Neuropharmacology Platforms highlight potential applications in neurological research, disease modeling, and drug discovery, showcasing CCLabs’ broader vision of integrating biological intelligence with next-generation computing systems.
CCLabs Best Patent
US20250087338A1 is the most popular patent in the CCLabs portfolio. It has received 3 citations so far from company like Infineon Technologies.
What Percentage of CCLabs US Patent Applications were Granted?
CCLabs (Excluding its subsidiaries) has filed 6 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 100.0%.
Below are the key stats of CCLabs patent prosecution at the USPTO.
Which Law Firms are managing US Patents for CCLabs?
| Law Firm | Total Applications | Success Rate |
| Patent Docket Administrator | 6 | 100.00% |
List of CCLabs Patents
| CCLabs Patents | Title |
| DE602020069195T2 | Method For Shaping A Diamond Coating On A Carbon Material |
| US20260049996A1 | Modification Of Voltage-Gated Channels In Neurons With Fluorescent Donor-Acceptor Pairs |
| EP4696333A1 | Modification Of Voltage-Gated Channels In Neurons With Fluorescent Donor-Acceptor Pairs |
| US12312575B1 | Closed-Loop Perfusion Circuit For Cell And Tissue Cultures |
| US12223409B2 | Biological Computing Platform |
| US20250087338A1 | Encoding Data For And Decoding Data From In Vitro Neuron Stimulation |
| EP4423753A4 | System And Method For Training In Vitro Neurons |
| EP4423751A4 | System And Method For Testing Effects Of Chemical Compounds |
| WO2025050166A1 | Encoding Data For And Decoding Data From In Vitro Neuron Stimulation |
| US11898135B1 | Closed-Loop Perfusion Circuit For Cell And Tissue Cultures |
| AU2022375207A1 | System And Method For Training In Vitro Neurons |
| AU2022375206A1 | System And Method For Testing Effects Of Chemical Compounds |
| KR1020240147656A | Systems And Methods For In Vitro Neuron Training |
| KR1020240141716A | Systems And Methods For Testing The Effects Of Chemical Compounds |
| US11651188B1 | Biological Computing Platform |
| US20230134609A1 | System And Method For Training In Vitro Neurons Using Hybrid Optical/Electrical System |
| US20230139724A1 | System And Method For Testing Effects Of Chemical Compounds On Cognitive Function |
| US20230133430A1 | System And Method For Training In Vitro Neurons |
| WO2023070168A1 | System And Method For Training In Vitro Neurons |
| WO2023070163A1 | System And Method For Testing Effects Of Chemical Compounds |
What are CCLabs key innovation segments?
The chart below distributes patents filed by CCLabs in different countries on the basis of the technology protected in patents. It also represents the markets where CCLabs thinks it’s important to protect particular technological inventions.
R&D Focus: How has CCLabs search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by CCLabs?
